AI healthcare specialist Reveal HealthTech has raised $7.2 million in a Series A round led by Leo Capital, with participation from Sanos Capital. Existing backers W Health Ventures and 2070 Health, which incubated the company in 2023, also continued to support it.
Co-founder and CEO Sanchit Mullick told TOI that the funding will be used to expand go-to-market teams and commercialize pre-built AI solutions such as BioCanvas and Prism AI. “So far we’ve really been doing founder-led sales. Now we want to scale our market education efforts while also investing in making our solutions commercial grade,” he said.
Mullick, a former Infosys executive who incubated AI services at the IT major, teamed up with co-founder Dr. Salim, a pediatric vascular surgeon formerly at Boston Children’s Hospital. “We arrived at this thesis based on two decades of digital plumbing in US healthcare through EHRs and RCMS. There was a gold mine of data, but little clarity on which business problems to solve,” Mullick said.
Reveal began by working on problem definition for US healthcare and lifesciences companies combing clinical insight with deep tech capabilities.
“We wanted to take a services-first approach, not build a product and push it to market” Mullick added.
The company says its solutions, such as BioCanvas, integrate structured EHR data with image data from CTs and MRIs to help in areas like oncology, clinical trial recruitment, and patient cohort creation. It is also piloting AI workfloew auotmation tools like Prism AI.
Mullick said barriers to adoption are less about data avaibility and more about regulation ad culture. “One uncertainty is how the regulatory landscape will shape up for AI in healthcare. The other is psychological safety. Employees often fear AI tools will replace them,” he said. To address this, Reveal built a design centre in Providence, Rhode Island, focusing on user experience and integration into existing workflows.
The company said it works with clients ranging from lrading pharma companies to healthcare delivery networks and digital health innovators. Its recent deployments include improving patient adherence for a $40 billion US medical device maker.
